Thailand Center of Excellence for Life Sciences ( T CELS ) · PDF fileThailand Center of...

20
Global Cluster Hub workshop: Cluster Internationalisation Thailand Center of Excellence for Life Sciences ( T CELS ) DR. NARES DAMRONGCHAI CEO November 3, 2015 @ BIO-Europe, Munich, Germany

Transcript of Thailand Center of Excellence for Life Sciences ( T CELS ) · PDF fileThailand Center of...

Global Cluster Hub workshop: Cluster Internationalisation

Thailand Center of Excellence for Life Sciences ( T CELS ) DR. NARES DAMRONGCHAI

CEO

November 3, 2015 @ BIO-Europe, Munich, Germany

2

Background Thailand as the Gateway to ASEAN

Thailand as the gateway to ASEAN

• Association of Southeast Asian Nations (ASEAN), and easy access into the Greater Mekong sub-region, where newly emerging markets offer great business potential.

• Offers convenient trade with China, India, largest growing economic market.

• ASEAN Economic Community (AEC), will enter into force by the end of 2015.

New Comer with a Vision

To make Thailand a world-class center for life sciences innovation and investment

Mission: Life Sciences Value Chain Execution

TCELS is a Thai government public organization. Our mission is to connect, construct and foster life sciences industry value chain through translation and acceleration of research to market

Research community Entrepreneurs

investors Public sector

Thailand Science Park, Northern Bangkok

Phase I

6

Thailand Science Park, Northern Bangkok

7

Phase II

R&D Focus: Bioresources and Tropical Diseases National Center for Biotechnology and Genetic Engineering

◦ Website: http://www.biotec.or.th

◦ Thailand Bioresource Research Center (TBRC)

◦ Medical Molecular Biology Research Unit ◦ Malaria

◦ Tuberculosis

◦ National Biopharmaceutical Facility (NBF)

9

FOCUS: Cell and Gene Therapy 1. Excellent Center for Drug Discovery (early 2016-) 2. Pilot Plant for Cell and Tissue Production Center (early 2016-)

cGMP Facility

Early Phase

Late Phase

- Grade A, B, C and D clean rooms, BSL2 (Biosafety level 2)

- Quality management system (QA/QC) - Process development for the

manufacture of cells for phase I, II clinical trials

3. Automated cell processing system (early 2016-)

Western Bangkok Biomedical Corridor

Source: Compiled from JCI certifications and data from Development Bank of Japan, 2014

Number of Medical Institutions in Major Asian Countries with JCI Certifications

Clinical Trials

• Data Management Unit: Tropical Medicine; MU, CU, TU, CMU

• Ethics: Joint Research Ethical Committees (JREC) for multi-center studies, FERCIT,

FERCAP

• CROs: ACLIRES, AGR, Clinical Development Services:

The Covance Advantage, etc.

• Bioequivalence Center: IBS, with ICH-GCP and OECD-GLP guidelines, study

protocols, internal SOPs and relevant regulatory requirements.

• Strong hospital sector growth reflecting the ongoing modernization of the healthcare industry Private: The Bumrungrad International Clinical Research Center (BICRC),

Public Clinical Research Center: Siriraj, CMU, KK, CRI, CU, Trop Med (Follow GCP Guideline)

13

Track Records of Success in Medical Tourisms

2010 2011 2012

No. of Medical tourists (person)

1,980.000 2,240,000 2,530

Estimated Revenue (Mil.USD)

2,400 3,000 4,300

Top 5 medical tourists by nationality

Japan ASEAN Middle East US UK

Japan ASEAN Middle East US UK

Japan US UK Middle East Australia

Medical

Hub Tourism Medical

Tourism

Resour

ces

R&D Technolo

gy

Raw &

Material

Manufactu

ring Investment &

Fund Infrastruc

ture

Regulatio

n

Conceptual Framework

Sustainable

Thailand’s Special Economic Zone: New Opportunity Arises

Thailand’s Special Economic Zone: Regional cluster development

Project “Medicopolis” is a plan to develop regional life sciences clusters based on indigenous capability, high technology, and tourism.

There are currently 3 potential locations in Eastern, Northeastern, and Southern Thailand.

Potentially to become “Life Sciences Zone” focusing on specific sectors e.g. medical devices and natural products.

MEDICOPOLI

S

by

TCELS

MEDICOPOLI

S

by

TCELS

MEDICOPOLI

S

by

TCELS

Our Challenges Attracting international partners has been first priority

◦ Political stability?

◦ Regulatory harmonization?

Investment regimes and incentives ◦ Are they competitive enough?

Human resources ◦ Researchers – talent mobility program

◦ Commercialization professionals

18

Coordinating Center

& Program • HRD APEC LSIF - Provide Strategic Direction

Regional

Implementation Center Provide up to date

contents for training

Building APEC economies capacity to commercialize their biomedical research & innovation